FAQs About Ruzurgi for LEMS
FAQs
Ruzurgi (amifampridine) is a medication by Jacobus Pharmaceutical for the treatment of Lambert-Eaton myasthenic syndrome (LEMS). The U.S. Food and Drug Administration approved Ruzurgi to treat LEMS patients ages 6 ... Read more